Founded in 1981, BTG International is a specialty pharmaceutical company that provides products for critical care, cancer, and neurological and other disorders. Its internal developmental pipelines include clinical stage and partnered development programs. The company s products include ViperaTAb, Voraxaze, Campath, DigiFab, BeneFIX and CroFab. BTG International supplies products throughout the world through various distribution agents. It serves clients in Australia, Belgium, France, Germany, Canada, Italy and France.